Sarah A. Teichmann
Director · 10x Genomics, Inc.
IndividualSelling only3 10b5-1 trades
- 2026
- Aug 17, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Sarah A. Teichmann files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Serge Saxonov - $6.82M in TXG purchases and sales in the last 12 months
- Adam Taich - $4.84M in TXG purchases and sales in the last 12 months
- John R. Stuelpnagel - $2.39M in TXG purchases and sales in the last 12 months
- Benjamin J. Hindson - $1.46M in TXG purchases and sales in the last 12 months
- Shehnaaz Suliman - $792K in TXG purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sarah A. Teichmann?
Sarah A. Teichmann is a corporate insider, tracked as Director of 10x Genomics, Inc. (TXG). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Sarah A. Teichmann submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Sarah A. Teichmann been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($579K) across all tracked filings.
